
NAPOLI 3, POUT, & Ivosidenib - Azole DDIs
OncoPharm
00:00
NAPOLI‑3 statistical assumptions and power
John explains the study's assumptions, sample size (≈750–770), hazard ratio target, and power calculations.
Play episode from 04:13
Transcript

John explains the study's assumptions, sample size (≈750–770), hazard ratio target, and power calculations.